| CENTER ID: | LedoB.01391.a |
| ORGANISM: | Leishmania donovani BPK282A1 |
| ASSOCIATED DISEASE: | Leishmaniasis |
| CURRENT STATUS: | soluble |
| COMMUNITY REQUEST: | True |
| NIH RISK GROUP: | 2 |
| SELECT AGENT: | False |
| NIH PRIORITY pathogens category: |
unclassified |
| CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
|---|---|---|---|---|---|
| LedoB.01391.a.HZ2.GE43876 | cDMRT domain | 13 | 302 | ||
| LedoB.01391.a.HZ3.GE43710 | kinase domain (Jensen) | 1 | 359 |
| RESOURCE | REFERENCE ID |
|---|---|
| EuPathDB: | TriTrypDB:LdBPK_360780.1 |
| UniProt: | E9BTD7 |
| HARVESTED ON: | 11/2/2020 |
| SEQUENCED ON: | 12/2/2020 |
| EXPECTED MW: | 47kDa |
| OBSERVED MW: | 47kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Good (10-50) |
| TOTAL EXPRESSION LEVEL: | Moderate Expression |
| SOLUBLE EXPRESSION LEVEL | Insoluble |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | 100 |
| PERCENT COVERAGE: | 99 |
| HARVESTED ON: | 7/6/2020 |
| SEQUENCED ON: | 6/23/2020 |
| EXPECTED MW: | 55kDa |
| OBSERVED MW: | 55kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Good (10-50) |
| TOTAL EXPRESSION LEVEL: | Moderate Expression |
| SOLUBLE EXPRESSION LEVEL | Moderate Expression |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | 92 |
| PERCENT COVERAGE: | 63 |